13D/13G Filings - AGIOS PHARMACEUTICALS INC. (AGIO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-08
10:15 am
Sale
2021-02-05 13G Agios Pharmaceuticals, Inc.
AGIO
FMR CORP 4,338,666
6.264%
-204,140decrease
(-4.49%)
Filing
History
2021-02-03
1:22 pm
Sale
2020-12-31 13G Agios Pharmaceuticals, Inc.
AGIO
WELLINGTON MANAGEMENT CO LLP 7,877,370
11.370%
-98,453decrease
(-1.23%)
Filing
History
2021-01-28
5:55 pm
Purchase
2020-12-31 13G Agios Pharmaceuticals, Inc.
AGIO
BLACKROCK INC
BLK
4,485,000
6.500%
591,606increase
(+15.20%)
Filing
History
2020-11-09
8:26 pm
Sale
2020-11-10 13G Agios Pharmaceuticals, Inc.
AGIO
Capital International Investors 220,510
0.300%
-4,428,964decrease
(-95.26%)
Filing
History
2020-08-10
09:25 am
Sale
2020-08-07 13G Agios Pharmaceuticals, Inc.
AGIO
FMR CORP 4,542,806
6.573%
-4,285,656decrease
(-48.54%)
Filing
History
Goto Prev, 0, 1, 2